Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Seung Hyun Kim, Woo Kyoung Jeong, Yongsoo Kim, Min Yeong Kim, Jinoo Kim, Ju Yeon Pyo, Young Ha Oh

Clin Mol Hepatol. 2013;19(1):92-96. Published online March 25, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.1.92

View: 7105 Download: 76 Web of Science: 10 Crossref: 11

Jae Yoon Jeong, Joo Hyun Sohn, Tae Yeob Kim, Woo Kyoung Jeong, Jinoo Kim, Ju Yeon Pyo, Young Ha Oh

Clin Mol Hepatol. 2012;18(2):239-244. Published online June 26, 2012

DOI: https://doi.org/10.3350/cmh.2012.18.2.239

View: 7878 Download: 111 Crossref: 11

Woo Jung Choi, Woo Kyoung Jeong, Yongsoo Kim, Jinoo Kim, Ju Yeon Pyo, Young Ha Oh

Clin Mol Hepatol. 2012;18(1):101-104. Published online March 22, 2012

DOI: https://doi.org/10.3350/kjhep.2012.18.1.101

View: 8043 Download: 59 Crossref: 6

1 |

Viewed By 5421	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5389	MAFLD: How is it different from NAFLD?
Viewed By 5276	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3943	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3930	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 77	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 68	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 52	MAFLD: How is it different from NAFLD?

Search